925
Views
65
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Primary diffuse large B-cell lymphomas of central nervous system exhibit remarkably high prevalence of oncogenic MYD88 and CD79B mutations

, , &
Pages 2141-2145 | Received 05 Aug 2014, Accepted 15 Oct 2014, Published online: 14 Jan 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Tarsheen K. Sethi, Alexandra E. Kovach, Natalie S. Grover, Li-Ching Huang, Laura A. Lee, Samuel M. Rubinstein, Yang Wang, David S. Morgan, John P. Greer, Steven I. Park, Mary Ann Thompson-Arildsen, Ashwini Yenamandra, Cindy L. Vnencak-Jones & Nishitha M. Reddy. (2019) Clinicopathologic correlates of MYD88 L265P mutation and programmed cell death (PD-1) pathway in primary central nervous system lymphoma. Leukemia & Lymphoma 60:12, pages 2880-2889.
Read now
Mareike Frick, Marcus Bettstetter, Simone Bertz, Stephan Schwarz-Furlan, Arndt Hartmann, Thomas Richter, Dido Lenze, Michael Hummel, Martin Dreyling, Georg Lenz & Andreas Gaumann. (2018) Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL. Leukemia & Lymphoma 59:5, pages 1260-1263.
Read now
Vincent Camus, Elodie Bohers, Sydney Dubois, Hervé Tilly & Fabrice Jardin. (2018) Circulating tumor DNA: an important tool in precision medicine for lymphoma. Expert Review of Precision Medicine and Drug Development 3:1, pages 11-21.
Read now
Vincent Camus, Fabrice Jardin & Herve Tilly. (2017) The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential. Expert Review of Molecular Diagnostics 17:6, pages 557-566.
Read now
Vincent Camus, Nasrin Sarafan-Vasseur, Elodie Bohers, Sydney Dubois, Sylvain Mareschal, Philippe Bertrand, Pierre-Julien Viailly, Philippe Ruminy, Catherine Maingonnat, Emilie Lemasle, Aspasia Stamatoullas, Jean-Michel Picquenot, Marie Cornic, Ludivine Beaussire, Christian Bastard, Thierry Frebourg, Hervé Tilly & Fabrice Jardin. (2016) Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 57:9, pages 2171-2179.
Read now

Articles from other publishers (60)

Claudio Agostinelli, Luca Morandi, Simona Righi, Luigi Cirillo, Marica Iommi, Caterina Tonon, Diego Mazzatenta, Matteo Zoli, Maura Rossi, Gianmarco Bagnato, Alessandro Broccoli, Raffaele Lodi, Pier Luigi Zinzani, Elena Sabattini, Caterina Giannini & Sofia Asioli. (2023) Genomic Profiling of Primary Diffuse Large B-cell Lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets. Modern Pathology 36:12, pages 100323.
Crossref
Junid A. Naveed Ahmad, Brett A. Schroeder, John Paul T. Yun & David M. Aboulafia. (2023) Mixed Diffuse and Tumoral Form of Bing-Neel Syndrome Successfully Treated with Ibrutinib. Case Reports in Oncology, pages 1353-1361.
Crossref
Xin He, Xiaotong Fan, Yongzhi Shan, Xinrui JiLan SuYaming Wang. (2023) Analysis of genomic alterations in primary central nervous system lymphoma. Medicine 102:35, pages e34931.
Crossref
Sarah J. Schep, Josephine M.I. Vos & Monique C. Minnema. (2023) Evaluation and Management of Bing–Neel Syndrome. Hematology/Oncology Clinics of North America 37:4, pages 777-786.
Crossref
Rachel Whitehair, Rasim Ozgur Rosti & Ifeyinwa E. Obiorah. (2023) Molecular Classification of Diffuse Large B Cell Lymphoma. Advances in Molecular Pathology.
Crossref
Toshikatsu Kaburaki & Kazuki Taoka. (2023) Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives. Japanese Journal of Ophthalmology 67:4, pages 363-381.
Crossref
Rui Zhang, Boyuan Wei, Yiyang Hu, Wenying Lv, Abudurexiti Adilai, Fan Yang, Jianning Zhang & Gang Cheng. (2023) Whole-Exome Sequencing Revealed the Mutational Profiles of Primary Central Nervous System Lymphoma. Clinical Lymphoma Myeloma and Leukemia 23:4, pages 291-302.
Crossref
Josefine Radke, Naveed Ishaque, Randi Koll, Zuguang Gu, Elisa Schumann, Lina Sieverling, Sebastian Uhrig, Daniel Hübschmann, Umut H. Toprak, Cristina López, Xavier Pastor Hostench, Simone Borgoni, Dilafruz Juraeva, Fabienne Pritsch, Nagarajan Paramasivam, Gnana Prakash Balasubramanian, Matthias Schlesner, Shashwat Sahay, Marc Weniger, Debora Pehl, Helena Radbruch, Anja Osterloh, Agnieszka Korfel, Martin Misch, Julia Onken, Katharina Faust, Peter Vajkoczy, Dag Moskopp, Yawen Wang, Andreas Jödicke, Lorenz Trümper, Ioannis Anagnostopoulos, Dido Lenze, Ralf Küppers, Michael Hummel, Clemens A. Schmitt, Otmar D. Wiestler, Stephan Wolf, Andreas Unterberg, Roland Eils, Christel Herold-Mende, Benedikt Brors, Reiner Siebert, Susanne Wagner, Andrea Haake, Julia Richter, Gesine Richter, Roland Eils, Chris Lawerenz, Jürgen Eils, Jules Kerssemakers, Christina Jaeger-Schmidt, Ingrid Scholz, Anke K. Bergmann, Christoph Borst, Friederike Braulke, Birgit Burkhardt, Alexander Claviez, Martin Dreyling, Sonja Eberth, Hermann Einsele, Norbert Frickhofen, Siegfried Haas, Martin-Leo Hansmann, Dennis Karsch, Nicole Klepl, Michael Kneba, Jasmin Lisfeld, Luisa Mantovani-Löffler, Marius Rohde, German Ott, Christina Stadler, Peter Staib, Stephan Stilgenbauer, Thorsten Zenz, Martin-Leo Hansmann, Dieter Kube, Siegfried Haas, Wolfram Klapper, Ulrike Kostezka, Peter Möller, Andreas Rosenwald, German Ott, Monika Szczepanowski, Ole Ammerpohl, Sietse M. Aukema, Vera Binder, Arndt Borkhardt, Andrea Haake, Jessica I. Hoell, Ellen Leich, Peter Lichter, Cristina López, Inga Nagel, Jordan Pischimariov, Bernhard Radlwimmer, Julia Richter, Philip Rosenstiel, Andreas Rosenwald, Markus Schilhabel, Stefan Schreiber, Inga Vater, Rabea Wagener, Reiner Siebert, Stephan H. Bernhart, Hans Binder, Gero Doose, Roland Eils, Steve Hoffmann, Lydia Hopp, Kortine Kleinheinz, Helene Kretzmer, Markus Kreuz, Jan Korbel, David Langenberger, Markus Loeffler, Maciej Rosolowski, Peter F. Stadler, Stephanie Sungalee, Reiner Siebert, Stefan Wiemann & Frank L. Heppner. (2022) The genomic and transcriptional landscape of primary central nervous system lymphoma. Nature Communications 13:1.
Crossref
Abdelrahman Nanah & Samer Al Hadidi. (2022) Bing-Neel Syndrome: Update on the Diagnosis and Treatment. Clinical Lymphoma Myeloma and Leukemia 22:3, pages e213-e219.
Crossref
Rongrong Chen, De Zhou, Lulu Wang, Lixia Zhu & Xiujin Ye. (2022) MYD88 L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy . Therapeutic Advances in Hematology 13, pages 204062072110728.
Crossref
Yuki Yamagishi, Nobuyoshi Sasaki, Yoshiko Nakano, Yuko Matushita, Takaki Omura, Saki Shimizu, Kuniaki Saito, Keiichi Kobayashi, Yoshitaka Narita, Akihide Kondo, Yoshiaki Shiokawa, Motoo Nagane & Koichi Ichimura. (2021) Liquid biopsy of cerebrospinal fluid for MYD88 L265P mutation is useful for diagnosis of central nervous system lymphoma . Cancer Science 112:11, pages 4702-4710.
Crossref
Boyuan Wei, Zhe Liu, Yue Fan, Shuwei Wang, Chao Dong, Wei Rao, Fan Yang, Gang Cheng & Jianning Zhang. (2021) Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing. Frontiers in Oncology 11.
Crossref
Seiji Yamada, Jun Muto, Sachiko Iba, Kazuya Shiogama, Yuta Tsuyuki, Akira Satou, Shigeo Ohba, Kazuhiro Murayama, Yasuo Sugita, Shigeo Nakamura, Hideaki Yokoo, Akihiro Tomita, Yuichi Hirose, Tetsuya Tsukamoto & Masato Abe. (2021) Primary central nervous system lymphomas with massive intratumoral hemorrhage: Clinical, radiological, pathological, and molecular features of six cases. Neuropathology 41:5, pages 335-348.
Crossref
Hua You, Li Wei & Bozena Kaminska. (2021) Emerging insights into origin and pathobiology of primary central nervous system lymphoma. Cancer Letters 509, pages 121-129.
Crossref
Claudio Ortolani. 2021. Flow Cytometry of Hematological Malignancies. Flow Cytometry of Hematological Malignancies 301 427 .
Peifeng Li, Jia Chai, Zi Chen, Yang Liu, Jie Wei, Yixiong Liu, Danhui Zhao, Jing Ma, Kaijing Wang, Xia Li, Yang Shao, Li Gong, Wei Zhang, Shuangping Guo, Qingguo Yan, Mingyang Li, Linni Fan & Zhe Wang. (2021) Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma. Frontiers in Oncology 11.
Crossref
Olimpia E Curran, Michael T C Poon, Louise Gilroy, Antonia Torgersen, Colin Smith & Wael Al-Qsous. (2021) MYD88 L265P mutation in primary central nervous system lymphoma is associated with better survival: A single-center experience. Neuro-Oncology Advances 3:1.
Crossref
Mohamad Barakat, Maher Albitar, Robin Whitney & Haifaa Abdulhaq. (2021) Diversity of genetic alterations of primary central nervous system lymphoma in Hispanic versus non-Hispanic patients. Cancer Treatment and Research Communications 27, pages 100310.
Crossref
Ketan R. Bulsara, Anzhela D. Moskalik, Joshua Knopf & Rebecca Calafiore. 2021. The Human Hypothalamus. The Human Hypothalamus 367 386 .
Jing Zhang, Liqiang Fu, Bin Shen, Yingtao Liu, Wenqian Wang, Xin Cai, Linglong Kong, Yilin Yan, Ryan Meng, Zhuming Zhang, Ying-Nan P. Chen, Qian Liu, Zhao-Kui Wan, Tianyuan Zhou, Xiaotao Wang, Paul Gavine, Amanda Del Rosario, Kay Ahn, Ulrike Philippar, Ricardo Attar, Jennifer Yang, Yanping Xu, James P. Edwards & Xuedong Dai. (2020) Assessing IRAK4 Functions in ABC DLBCL by IRAK4 Kinase Inhibition and Protein Degradation. Cell Chemical Biology 27:12, pages 1500-1509.e13.
Crossref
Noriko Nishimura, Kengo Takeuchi, Reimi Asaka, Naoko Tuyama, Norihito Inoue, Yoshiharu Kusano, Yuko Mishima, Masahiro Yokoyama & Yasuhito Terui. (2020) MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era. Leukemia Research 97, pages 106426.
Crossref
Julia Garcia-Reyero, Nerea Martinez Magunacelaya, Ainara Gonzalez Pereña, Sara Marcos Gonzalez, Nuria Teran-Villagra, Ainara Azueta, Ana Batlle, Sonia Gonzalez de Villambrosia, Jose Revert Arce & Santiago Montes-Moreno. (2020) Clonal Evolution in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System. Applied Immunohistochemistry & Molecular Morphology 28:8, pages e68-e71.
Crossref
Rebecca L. King, John R. Goodlad, Maria Calaminici, Snjezana Dotlic, Santiago Montes-Moreno, Ilske Oschlies, Maurilio Ponzoni, Alexandra Traverse-Glehen, German Ott & Judith A. Ferry. (2019) Lymphomas arising in immune-privileged sites: insights into biology, diagnosis, and pathogenesis. Virchows Archiv 476:5, pages 647-665.
Crossref
Kun Chen, Yanchun Ma, Tianling Ding, Xinju Zhang, Bobin Chen & Ming Guan. (2020) Effectiveness of digital PCR for MYD88L265P detection in vitreous fluid for primary central nervous system lymphoma diagnosis. Experimental and Therapeutic Medicine 20:1, pages 301-308.
Crossref
Csaba Bödör, Donát Alpár, Dóra Marosvári, Bence Galik, Hajnalka Rajnai, Bence Bátai, Ákos Nagy, Béla Kajtár, Adrienn Burján, Beáta Deák, Tamás Schneider, Hussain Alizadeh, András Matolcsy, Sebastian Brandner, James Storhoff, Ning Chen, Mingdong Liu, Nadeem Ghali, Irén Csala, Attila G Bagó, Attila Gyenesei & Lilla Reiniger. (2020) Molecular Subtypes and Genomic Profile of Primary Central Nervous System Lymphoma. Journal of Neuropathology & Experimental Neurology 79:2, pages 176-183.
Crossref
Manit Munshi, Xia Liu, Jiaji G. Chen, Lian Xu, Nickolas Tsakmaklis, Maria G. Demos, Amanda Kofides, Maria Luisa Guerrera, Cristina Jimenez, Gloria G. Chan, Zachary R. Hunter, M. Lia Palomba, Kimon V. Argyropoulos, Kirsten Meid, Andrew Keezer, Joshua Gustine, Toni Dubeau, Jorge J. Castillo, Christopher J. Patterson, Jinhua Wang, Sara J. Buhrlage, Nathanael S. Gray, Steven P. Treon & Guang Yang. (2020) SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomas. Blood Cancer Journal 10:1.
Crossref
Jun Watanabe, Manabu Natsumeda, Masayasu Okada, Daiki Kobayashi, Yu Kanemaru, Yoshihiro Tsukamoto, Makoto Oishi, Akiyoshi Kakita & Yukihiko Fujii. (2019) High Detection Rate of MYD88 Mutations in Cerebrospinal Fluid From Patients With CNS Lymphomas . JCO Precision Oncology:3, pages 1-13.
Crossref
Maria Ormhøj, Irene Scarfò, Maria L. Cabral, Stefanie R. Bailey, Selena J. Lorrey, Amanda A. Bouffard, Ana P. Castano, Rebecca C. Larson, Lauren S. Riley, Andrea Schmidts, Bryan D. Choi, Rikke S. Andersen, Oriane Cédile, Charlotte G. Nyvold, Jacob H. Christensen, Morten F. Gjerstorff, Henrik J. Ditzel, David M. Weinstock, Torben Barington, Matthew J. Frigault & Marcela V. Maus. (2019) Chimeric Antigen Receptor T Cells Targeting CD79b Show Efficacy in Lymphoma with or without Cotargeting CD19. Clinical Cancer Research 25:23, pages 7046-7057.
Crossref
Ryan M. Young, James D. Phelan, Wyndham H. Wilson & Louis M. Staudt. (2019) Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment. Immunological Reviews 291:1, pages 190-213.
Crossref
Adalgisa Condoluci & Davide Rossi. (2019) The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomas. Current Opinion in Hematology 26:4, pages 281-287.
Crossref
Vaishali Aggarwal, Ashim Das, Amanjit Bal, Radhika Srinivasan, Reena Das, Gaurav Prakash, Pankaj Malhotra & Subhash Varma. (2019) MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma. Applied Immunohistochemistry & Molecular Morphology 27:4, pages 311-318.
Crossref
Ryan M. YoungJames D. PhelanArthur L. ShafferIIIIIIGeorge W. Wright, Da Wei HuangRoland SchmitzCalvin Johnson, Thomas OellerichWyndham WilsonLouis M. Staudt. (2019) Taming the Heterogeneity of Aggressive Lymphomas for Precision Therapy. Annual Review of Cancer Biology 3:1, pages 429-455.
Crossref
Magdalena Klanova, Laurie H. SehnIsabelle Bence-Bruckler, Federica Cavallo, Jie JinMaurizio Martelli, Douglas StewartUmberto Vitolo, Francesco ZajaQingyuan ZhangFederico MattielloGila Sellam, Elizabeth A. Punnoose, Edith Szafer-Glusman, Christopher R. Bolen, Mikkel Z. Oestergaard, Guenter R. Fingerle-RowsonTina NielsenMarek Trneny. (2019) Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL. Blood 133:9, pages 919-926.
Crossref
Naema Nayyar, Michael D. White, Corey M. Gill, Matthew LastrapesMia Bertalan, Alexander KaplanMegan R. D’AndreaIvanna BihunAndrew KanebJorg DietrichJudith A. FerryMaria Martinez-LageAnita Giobbie-HurderDarrell R. BorgerFausto J. Rodriguez, Matthew P. FroschEmily BatchelorKaitlin HoangBenjamin KuterSarah FortinMatthias HoldhoffDaniel P. Cahill, Scott Carter, Priscilla K. BrastianosTracy T. Batchelor. (2019) MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas. Blood Advances 3:3, pages 375-383.
Crossref
Ichiro Yonese, Hiroshi Takase, Mayumi Yoshimori, Erika Onozawa, Akiho Tsuzura, Tohru Miki, Manabu Mochizuki, Osamu Miura & Ayako Arai. (2018) CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential . European Journal of Haematology 102:2, pages 191-196.
Crossref
Cora Hallas, Michael Preukschas & Markus Tiemann. (2019) Immunohistochemical distinction of ABC and GCB in extranodal DLBCL is not reflected in mutation patterns. Leukemia Research 76, pages 107-111.
Crossref
Soheil Zorofchian, Hanadi El-Achi, Yuanqing Yan, Yoshua Esquenazi & Leomar Y. Ballester. (2018) Characterization of genomic alterations in primary central nervous system lymphomas. Journal of Neuro-Oncology 140:3, pages 509-517.
Crossref
Yoshitaka Yamasaki, Fumihiko Mouri, Shuki Ohya, Takayuki Nakamura, Satoshi Morishige, Maki Yamaguchi, Atsushi Nonami, Ritsuko Seki, Koichi Osaki & Koji Nagafuji. (2018) A Case of Bing-Neel Syndrome Presenting as Vision Impairment and Numbness視力障害としびれが初発症状のBing-Neel症候群. Nihon Naika Gakkai Zasshi 107:10, pages 2154-2161.
Crossref
Laura S. Hiemcke-Jiwa, Roos J. Leguit, Tom J. Snijders, N. Mehdi Jiwa, Jonas. J.W. Kuiper, Roel A. de Weger, Monique C. Minnema & Manon M.H. Huibers. (2018) Molecular analysis in liquid biopsies for diagnostics of primary central nervous system lymphoma: Review of literature and future opportunities. Critical Reviews in Oncology/Hematology 127, pages 56-65.
Crossref
Shingo Takano, Keiichiro Hattori, Eiichi Ishikawa, Yoshitaka Narita, Yasuo Iwadate, Fumio Yamaguchi, Motoo Nagane, Jiro Akimoto, Hidehiro Oka, Satoshi Tanaka, Mamiko Sakata, Masahide Matsuda, Tetsuya Yamamoto, Shigeru Chiba & Akira Matsumura. (2018) MyD88 Mutation in Elderly Predicts Poor Prognosis in Primary Central Nervous System Lymphoma: Multi-Institutional Analysis. World Neurosurgery 112, pages e69-e73.
Crossref
Keiichiro Hattori, Mamiko Sakata‐Yanagimoto, Yasuhito Suehara, Yasuhisa Yokoyama, Takayasu Kato, Naoki Kurita, Hidekazu Nishikii, Naoshi Obara, Shingo Takano, Eiichi Ishikawa, Akira Matsumura, Yuichi Hasegawa & Shigeru Chiba. (2017) Clinical significance of disease‐specific MYD 88 mutations in circulating DNA in primary central nervous system lymphoma . Cancer Science 109:1, pages 225-230.
Crossref
Agathe Debliquis, Jimmy Voirin, Inès Harzallah, Maxime Maurer, Felix Lerintiu, Bernard Drénou & Guido Ahle. (2016) Cytomorphology and flow cytometry of brain biopsy rinse fluid enables faster and multidisciplinary diagnosis of large B‐cell lymphoma of the central nervous system. Cytometry Part B: Clinical Cytometry 94:1, pages 182-188.
Crossref
Mei Zheng, Anamarija M. Perry, Philip Bierman, Fausto LoberizaJr.Jr., Michel R. Nasr, David Szwajcer, Marc R. Del Bigio, Lynette M. Smith, Weiwei Zhang & Timothy C. Greiner. (2017) Frequency of MYD88 and CD79B mutations, and MGMT methylation in primary central nervous system diffuse large B-cell lymphoma . Neuropathology 37:6, pages 509-516.
Crossref
Christopher Mason, Steven Savona, Josephine N. Rini, Jorge J. Castillo, Lian Xu, Zachary R. Hunter, Steven P. Treon & Steven L. Allen. (2017) Ibrutinib penetrates the blood brain barrier and shows efficacy in the therapy of Bing Neel syndrome. British Journal of Haematology 179:2, pages 339-341.
Crossref
Xue-Liang Yang & Yuan-Bo Liu. (2017) Advances in Pathobiology of Primary Central Nervous System Lymphoma. Chinese Medical Journal 130:16, pages 1973-1979.
Crossref
Maxime Fontanilles, Florent Marguet, Élodie Bohers, Pierre-Julien Viailly, Sydney Dubois, Philippe Bertrand, Vincent Camus, Sylvain Mareschal, Philippe Ruminy, Catherine Maingonnat, Stéphane Lepretre, Elena-Liana Veresezan, Stéphane Derrey, Hervé Tilly, Jean-Michel Picquenot, Annie Laquerrière & Fabrice Jardin. (2017) Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma. Oncotarget 8:29, pages 48157-48168.
Crossref
Ju-Han Lee, Hoiseon Jeong, Jung-Woo Choi, HwaEun Oh & Young-Sik Kim. (2017) Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis. Scientific Reports 7:1.
Crossref
Keiichiro Hattori, Mamiko Sakata-Yanagimoto, Yasushi Okoshi, Yuki Goshima, Shintaro Yanagimoto, Rie Nakamoto-Matsubara, Taiki Sato, Masayuki Noguchi, Shingo Takano, Eichi Ishikawa, Tetsuya Yamamoto, Akira Matsumura & Shigeru Chiba. (2017) MYD88 (L265P) mutation is associated with an unfavourable outcome of primary central nervous system lymphoma . British Journal of Haematology 177:3, pages 492-494.
Crossref
Semra Paydas. (2017) Primary central nervous system lymphoma: essential points in diagnosis and management. Medical Oncology 34:4.
Crossref
Toshifumi Takeuchi, Motoko Yamaguchi, Kyoko Kobayashi, Kana Miyazaki, Isao Tawara, Hiroshi Imai, Ryoichi Ono, Tetsuya Nosaka, Kyosuke Tanaka & Naoyuki Katayama. (2017) MYD88 , CD79B , and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma . Cancer 123:7, pages 1166-1173.
Crossref
Roger G. Owen, Andy C. Rawstron & Ruth M. de Tute. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia 3 19 .
Yang Song, Wei Zhang, Li Zhang, Wei Wu, Yan Zhang, Xiao Han, Chen Yang, Lu Zhang & Daobin Zhou. (2016) Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma. Scientific Reports 6:1.
Crossref
Keina Nagakita, Katsuyoshi Takata, Kohei Taniguchi, Tomoko Miyata‐Takata, Yasuharu Sato, Akira Tari, Nobuhiko Ohnishi, Mai Noujima‐Harada, Shizuma Omote, Naoya Nakamura, Masaya Iwamuro, Yoshinobu Maeda, Hiroyuki Okada, Mitsune Tanimoto & Tadashi Yoshino. (2016) Clinicopathological features of 49 primary gastrointestinal diffuse large B‐cell lymphoma cases; comparison with location, cell‐of‐origin, and frequency of MYD88 L265P. Pathology International 66:8, pages 444-452.
Crossref
Chengrui Yan, Xiangyi Kong, Lanshu Yang & Wenbin Ma. (2016) An uncommon case of lymphoplasmacytic lymphoma in cerebellopontine angle region. Medicine 95:34, pages e4627.
Crossref
Penelope Korkolopoulou, Theodoros Vassilakopoulos, Vassilios Milionis & Maria Ioannou. (2016) Recent Advances in Aggressive Large B-cell Lymphomas: A Comprehensive Review. Advances in Anatomic Pathology 23:4, pages 202-243.
Crossref
Kerry J. Savage, Graham W. SlackAnja MottokLaurie H. Sehn, Diego Villa, Roopesh Kansara, Robert KridelChristian SteidlDaisuke EnnishiKing L. TanSusana Ben-NeriahNathalie A. Johnson, Joseph M. Connors, Pedro FarinhaDavid W. Scott & Randy D. Gascoyne. (2016) Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL. Blood 127:18, pages 2182-2188.
Crossref
Kohei Taniguchi, Katsuyoshi Takata, Shih-Sung Chuang, Tomoko Miyata-Takata, Yasuharu Sato, Akira Satou, Yuko Hashimoto, Maiko Tamura, Keina Nagakita, Nobuhiko Ohnishi, Mai Noujima-Harada, Tetsuya Tabata, Yara Yukie Kikuti, Yoshinobu Maeda, Naoya Nakamura, Mitsune Tanimoto & Tadashi Yoshino. (2016) Frequent MYD88 L265P and CD79B Mutations in Primary Breast Diffuse Large B-Cell Lymphoma. American Journal of Surgical Pathology 40:3, pages 324-334.
Crossref
Jose S. Pulido, Harish Raja, Richard G. Vile, Diva R. Salomao & David S. Viswanatha. (2016) Mighty MyD88 in Health and Disease. Retina 36:3, pages 429-431.
Crossref
Steven H. Swerdlow, Isinsu Kuzu, Ahmet Dogan, Stephan Dirnhofer, John K. C. Chan, Birgitta Sander, German Ott, Luc Xerri, Leticia Quintanilla-Martinez & Elias Campo. (2015) The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Archiv 468:3, pages 259-275.
Crossref
Ryan M. YoungTianyi WuRoland SchmitzMoez DawoodWenming XiaoJames D. PhelanWeihong XuLaurence MenardEric MeffreWing-Chung C. ChanElaine S. JaffeRandy D. GascoyneElías CampoAndreas RosenwaldGerman OttJan DelabieLisa M. Rimsza & Louis M. Staudt. (2015) Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens. Proceedings of the National Academy of Sciences 112:44, pages 13447-13454.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.